Science Explorer Interactive view Map
Company · South San Francisco · United States

Ideaya Biosciences (United States)

ideayabio.comROR OpenAlex
Research works
38
▲ 580% vs 2013–17
Citations
887
23.3 per fractional work
Top-10% rate
11.1%
record average 16.5%
Open access
26%
world 28%

Not ranked overall: Ideaya Biosciences (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.29× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.63× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 1.02× its world share, 0 worksImmunology and Micro…Neuroscience: 0.28× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 17.23× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.47× its world share, 0 worksComputer ScienceEngineering: 0.14× its world share, 0 worksEngineeringHealth Professions: 0.15× its world share, 0 worksHealth ProfessionsMedicine: 1.96× its world share, 5 worksMedicineVeterinary: 9.99× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 17.2×. Every wedge is a field page.

Which keywords describe research at Ideaya Biosciences (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Transcriptional Regulation, Cancer Therapy, Homologous Recombination, Cell Death, Cell Proliferation, Arginine Methylation and Protein Arginine Methyltransferases.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 36 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 36 words, with their numbers
  1. Cancer6▲ 12×6 topics
  2. Transcriptional Regulation6▲ 62×4 topics
  3. Cancer Therapy4▲ 18×6 topics
  4. Homologous Recombination4▲ 167×2 topics
  5. Cell Death4▲ 52×4 topics
  6. Cell Proliferation4▲ 117×2 topics
  7. Arginine Methylation4▲ 311×1 topic
  8. Protein Arginine Methyltransferases4▲ 311×1 topic
  9. Synthetic Lethality3▲ 332×2 topics
  10. BRCA Mutation3▲ 431×1 topic
  11. PARP Inhibitors3▲ 431×1 topic
  12. Inflammation2▲ 2.6×11 topics
  13. Oxidative Stress2▲ 3.1×8 topics
  14. Genomic Instability2▲ 40×2 topics
  15. Immune Response2▲ 7.3×6 topics
  16. Chromatin2▲ 45×2 topics
  17. Genetic Mutations2▲ 8.3×4 topics
  18. BET Bromodomains2▲ 190×1 topic
  19. DNA Damage2▲ 29×1 topic
  20. DNA Methylation2▲ 35×1 topic
  21. Genetic Variation2▲ 12×3 topics
  22. Histone Modification2▲ 62×1 topic
  23. PROTACs2▲ 190×1 topic
  24. Repair2▲ 78×1 topic
  25. Tumor Microenvironment2▲ 11×4 topics
  26. Antiretroviral Therapy1▲ 16×4 topics
  27. Breast Cancer1▲ 13×3 topics
  28. Medicinal Chemistry1▲ 9.6×4 topics
  29. Prognostic Factors1▲ 7.1×2 topics
  30. Retinoblastoma1▲ 182×1 topic
  31. Uveal Melanoma1▲ 182×1 topic
  32. Reactive Oxygen Species1▲ 6.0×4 topics
  33. Cytochrome P4501▲ 37×2 topics
  34. Metabolism1▲ 4.1×2 topics
  35. Pharmacokinetics1▲ 9.8×2 topics
  36. Proteasome Inhibitors1▲ 38×2 topics

Which research topics does Ideaya Biosciences (United States) publish most on?

By volume in 2022–2025: PARP inhibition in cancer therapy, Cancer, Hypoxia, and Metabolism, Cancer Immunotherapy and Biomarkers and Cancer-related gene regulation.

PARP inhibition in cance…1PARP inhibition in cancer therapy: 1 fractional worksCancer, Hypoxia, and Met…1Cancer, Hypoxia, and Metabolism: 1 fractional worksCancer Immunotherapy and…1Cancer Immunotherapy and Biomarkers: 1 fractional worksCancer-related gene regu…0Cancer-related gene regulation: 0 fractional worksEpigenetics and DNA Methylation: 0 fractional worksProtein Degradation and Inhibitors: 0 fractional worksBiochemical and Molecula…0Biochemical and Molecular Research: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksCancer Genomics and Diagnostics: 0 fractional worksEndoplasmic Reticulum St…0Endoplasmic Reticulum Stress and Disease: 0 fractional works
OncologyCancer ResearchMolecular BiologyComputational Theory and Mathematics1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 PARP inhibition in cancer therapy Oncology 1 works
  2. 2 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Cancer-related gene regulation Molecular Biology 0 works
  5. 5 Epigenetics and DNA Methylation Molecular Biology 0 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 0 works
  7. 7 Biochemical and Molecular Research Molecular Biology 0 works
  8. 8 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  9. 9 Cancer Genomics and Diagnostics Cancer Research 0 works
  10. 10 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available25.9%not open74.1%

World: 28% of research is openly available.

with international co-authors19.5%domestic only80.5%

World: 19% is written across borders.

How has Ideaya Biosciences (United States)'s research output changed?

Output in 2018–2022 was 580% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in South San Francisco

All research institutions in South San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.